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hospital mortality rate of 12.3% (1). In the treatment of
acute ST elevation myocardial infarctions (STEMI),
both thrombolysis and percutaneous coronary
intervention (PCI) are proven reperfusion strategies to
decrease mortality (2-8). The initial landmark
thrombolysis trials demonstrating a mortality benefit
were completed in the late 1980's and early 1990's (2-
4). A meta-analysis of these trials published in 1994
demonstrated an absolute mortality benefit of 3% at 5
weeks in those patients treated within 6 hours of
symptom onset (5). In a further advancement, the
primary PCI trials demonstrated improved outcomes
when compared to thrombolysis (6, 7). For example, in
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INTRODUCTION
Acute myocardial infarction (AMI) is a leading cause
of morbidity and mortality in Canada. The Canadian
Cardiovascular Outcomes Research Team (CCORT)
showed that there were 139,523 new AMI cases in
Canada between 1997/98 and 1999/2000, with an in-
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ABSTRACT: Background: New published guidelines recommend treatment of ST elevation
myocardial infarction (STEMI) within 30 minutes of first medical contact to thrombolysis
and 90 minutes to primary percutaneous coronary intervention (PCI). Objectives: To
determine how a tertiary care center compares to these new guidelines and to evaluate the
success of measures directed to shorten delays. Methods: This was a prospectively designed
audit loop using retrospective chart review. Specific time intervals were evaluated: 1) T2 (ER
presentation to diagnostic EKG; 2) T ER (ER presentation to reperfusion); and 3) T AHA
(first medical contact to reperfusion). Results of the initial 12-month data were conveyed to
Emergency Room staff and a dedicated EKG machine was placed in the ER for the
subsequent 12 months, and the results were then re-analyzed. Results: In 2003-4, 58 patients
with STEMI were identified, with 41 (70.7%) receiving reperfusion. Of those receiving
thrombolysis, median T AHA was 54 [37-72] minutes, with 12.0% <30 minutes, while those
receiving PCI, median T AHA was 58 [43-78] minutes, with 25.0% <90 minutes. In 2004-5, 52
patients had STEMI, with 40 (76.9%) receiving reperfusion. The percentage of patients
meeting the guidelines was 14.3% for the thrombolysis group and 11.1% for the PCI group.
Introduction of  a dedicated EKG machine led to a strong trend towards improvement in
median T2 (22 vs 10 minutes; P=0.07), but other treatment times remained unchanged.
Conclusions: Treatment times are longer than recommended guidelines. More comprehensive
strategies and improved coordination of medical services are required to shorten pre-contact
and post-contact response times.
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umbhagir@cc.umanitoba.cathe DANAMI-2 trial, the primary end-point of
mortality, re-infarction, and stroke at 30 days was seen
in 8% of patients receiving PCI and 13.7% of patients
receiving thrombolysis (7).
Nonetheless, the optimal treatment modality has
continued to be an ongoing and contentious issue in
cardiovascular medicine (9-10). A recent review of 23
clinical trials by Keeley et al. suggests that primary PCI
is more effective than thrombolysis in reducing death
and non-fatal reinfarction (8). An essential caveat to this
is that the benefit achieved by timely reperfusion by
thrombolysis may be just as effective as PCI if there are
imminent delays foreseen in receiving PCI. Hence,
more important than the choice of initial reperfusion
strategy is the concept of receiving treatment in a timely
fashion, thus producing a similar degree of myocardial
salvage (11).
The 2004 American College of Cardiology/American
Heart Association (ACC/AHA) guidelines
recommended that thrombolysis or PCI be administered
within 30 or 90 minutes of first medical contact,
respectively (12). These new guidelines were also
reviewed and adapted for Canada by the Canadian
Working Group (CWG) (13). It should be noted that
these modifications were made from previous
ACC/AHA guidelines established in 1999, which
required thrombolysis or PCI to be administered within
30 or 90 minutes of arrival to hospital (14). With the
emphasis on timely treatment of STEMI, the objective
of our present study was to investigate how a tertiary
care center in Winnipeg compared to these new
guidelines over a 12 month period, looking specifically
at the various components of time delay in patients
receiving either thrombolysis or primary PCI. In this
prospectively designed closed-loop audit, we
subsequently made an attempt to rectify in-hospital time
delays by introducing a dedicated EKG machine to the
Emergency Room (ER) and by providing feedback on
the previous year's data to the ER staff.  We then re-
evaluated treatment times in the subsequent 12 months.  
METHODS
Study Design and Patient Population
This was a retrospective chart audit designed
prospectively to improve in-hospital time delays for
timely reperfusion.  The audit initiative was put forth by
the Section of Cardiology within the Departments of
Medicine and Cardiac Sciences and the Department of
Emergency Medicine. The protocol was consistent with
standards developed for audit-based research  in the
Winnipeg Regional Health Authority (WRHA) and the
University of Manitoba. Coded 'myocardial infarction'
charts were analyzed at St. Boniface General Hospital
initially between September 1st, 2003 and August 31st,
2004. Then, on September 1, 2004, a dedicated EKG
machine was introduced to the ER, and the next year's
charts were subsequently analyzed (September 1, 2004
and August 31, 2005). Furthermore, information from
the initial year's audit was conveyed to the ER staff.
Inclusion criteria included patients of at least 18 years
of age presenting with STEMI, as per the definition
consistent with ACC/AHA guidelines. Patients included
in the study were either direct walk-ins to the ER or
presented via EMS. Patients with NSTEMI, transferred
MI, and in-hospital or peri-operative MI were excluded.
There was no established mechanism developed in
deciding whether patients received PCI or thrombolysis.
In general, patients received PCI if there were clear
contraindications to thrombolysis, a pre-shock/shock
state was present, or if the cardiac catheterization suite
was conveniently available (ie: selective daytime PCI).
Data Collection
The data was collected by one of three authors (KB,
MK, KK). A fourth investigator (JWT) was available in
difficult cases, whereby decisions were made by
consensus. Data was recorded on standardized forms
designed by our investigative group, containing
information pertaining to patient demographics, clinical
presentation, and specific time intervals. Figure 1 below
illustrates the specific time intervals.
The patient-dependent time interval T1 represents the
elapsed time from symptom onset to first medical
contact, which could be in the form of direct
presentation to the ER or via EMS activation. Other
important time intervals include: 1) T2 (time from ER
presentation to first diagnostic EKG), 2) T3 (time from
diagnostic EKG to reperfusion), 3) T ER (time from ER
presentation to reperfusion, or 'door-to- needle/balloon'
time), and 4) T AHA (time from first medical contact to
Figure 1:  Flow diagram illustrating various components of the
treatment times analyzed in this study.
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reperfusion, as defined by the ACC/AHA guidelines).
Note that in cases with direct presentation to the ER by
walk-in, T AHA and T ER were identical.
Other important definitions used in this study were:
1) RRS (received reperfusion strategy), 2) NRS (no
reperfusion strategy), 3) RRS-L (received reperfusion
strategy - thrombolytics), and 4) RRS-P (received
reperfusion strategy - PCI).
Data Management and Analysis
The collected data was subsequently entered into a
database system (MS Excel, USA).  Statistical analysis
was completed with web-based software (15-16). The
c2 analysis was used to compare categorical data, while
the Wilcoxon test was used for the comparison of non-
parametric, continuous dataset. A p-value of <0.05 was
deemed to be statistically significant.  Statistics were
used to compare the following time intervals between
2003-4 and 2004-5: 1) T2, 2) T3, 3) T ER, and 4) T
AHA. Following the aforementioned change in the
subsequent year, we anticipated direct improvements in
T2 and T3, with corresponding improvements in T ER
and T AHA.
RESULTS
Preliminary results were presented elsewhere (17).  In
2003-4, a total of 58 patients diagnosed as having
STEMI were identified, and 41 (70.7%) patients
received reperfusion therapy. Of the patients who
received reperfusion, 25 (61.0%) patients received
thrombolysis, while 16 (39.0%) patients received
primary PCI. In 2004-5, 52 patients presented with
STEMI, with 40 (76.9%) patients having received
reperfusion therapy. Of these, 21 (52.5%) patients and
19 (47.5%) patients received thrombolysis and primary
PCI, respectively. Overall, the unadjusted, in-hospital
mortality rate for the entire group was 17% in 2003-4
and 12% in 2004-5 (p = NS). Other significant
demographic and clinical characteristics between the
two groups are outlined in Table 1. 
The specific time intervals for 2003-4 and 2004-5 are
shown in Tables 2 and 3, respectively, with data
recorded as the median time in minutes, including the
25th and 75th percentile.  
In the initial year (2003-4), the time from ER to the
first diagnostic EKG (T2) was 22 (13-33) minutes. For
patients who received reperfusion, the treatment time
(T3) was 20 (10-27) minutes in the thrombolysis group
and 90 (73-214) minutes in the primary PCI group. In
2004-5, there was overall a non-significant, but positive
trend toward improvement in T2, with 10 (7-39)
minutes elapsing between ER presentation and the first
diagnostic EKG (p=0.07). In comparison, T3 for
thrombolysis (19 (11-34) minutes, P=0.27) and primary
PCI (92 (71-118) minutes, P=0.39) was essentially
unchanged.  
Table 1: Demographic and clinical characteristics
Total STEMI Total STEMI
2003-2004 2004-2005
N  58 52
Age (Mean+/- SD) 64.5 +/- 14.0 63.6 +/- 15.0









CRF (%) 14.0 3.8
Previous MI (%) 27.6 8.0
Previous Angina (%) 37.9 28.0
Previous CABG (%) 6.9 8.0
Previous PCTA (%) 3.4 14.0
Treated DM2 (%) 15.5 6.0
Previous CHF (%) 5.2 6.0
Peak CK (median) 1173 960
Peak Trop (median) 4.02 2.76
Table 2: Specific time intervals for 2003-2004 (n=58)
Total STEMI RRS STEMI NRS STEMI RRS-L RRS-P
T1 (Symptom onset - First medical contact) 106 (67-191) 91 (56-166) 156 (106-201) 112 (62-180) 85 (48-128)
T2 (ER - Diagnostic EKG) 22 (13-33) 17 (12-28) 29 (22-53) 17 (13-25) 18 (12-28)
T3 (Diagnostic EKG - Reperfusion) 42 (14-80) 20 (10-27) 90 (73-214)
T ER (ER - Reperfusion) 72 (31-119) 34 (21-67) 117 (91-246)
T AHA (First medical contact - Reperfusion) 81 (49-124) 54 (37-72) 124 (92-255)
T Total (Symptom onset - Reperfusion) 166 (123-330) 148 (110-313) 195 (144-483)
*All times stated as median (25th-75th percentile), in minutes
RRS - Received Reperfusion Strategy
NRS - No reperfusion strategy
RRS-L - Received Reperfusion Strategy - Lytics 
RRS-P - Received Reperfusion Strategy - Primary PCI
77As outlined in Tables 4 and 5, the percentage of
patients meeting the previous standard vs. the newer
ACC/AHA guidelines between the 2 years was
compared for thrombolysis and primary PCI. In general,
fewer proportion of patients met the more stringent
guidelines. There was no statistically significant
difference in the proportion of patients receiving
treatment in the recommended time window between
2003-4 and 2004-5.
DISCUSSION AND CONCLUSIONS
The purpose of this prospectively designed closed-
loop audit was to determine how one tertiary care center
Table 3: Specific time intervals for 2004-2005 (n=52)
Total STEMI RRS STEMI NRS STEMI RRS-L RRS-P
T1 (Symptom onset - First medical contact) 96 (66-147) 101 (70-155) 96 (30-100) 94 (60-150) 108 (73-215)
T2 (ER - Diagnostic EKG) 10 (7-39) 10 (6-27) 21 (8-66) 10 (4-20) 10 (6-34)
T3 (Diagnostic EKG - Reperfusion) 42 (18-92) 19 (11-34) 92 (71-118)
T ER (ER - Reperfusion) 68 (25-123) 28 (18-59) 104 (91-137)
T AHA (First medical contact - Reperfusion) 91 (55-142) 58 (43-78) 139 (101-162)
T Total (Symptom onset - Reperfusion) 194 (160-269) 187 (120-260) 204 (176-272)
*All times stated as median (25th-75th percentile), in minutes
RRS - Received Reperfusion Strategy
NRS - No reperfusion strategy
RRS-L - Received Reperfusion Strategy - Lytics 
RRS-P - Received Reperfusion Strategy - Primary PCI
Table 4: Percentage of patients receiving thrombolysis within
the previously recommended guidelines and the newer
ACC/AHA guidelines between 2003-2004 and 2004-2005.
Patients (%) P-value














Table 5: Percentage of patients receiving thrombolysis within the
previously recommended guidelines and the newer ACC/AHA
guidelines between 2003-2004 and 2004-2005.
Patients (%) P-value














in Winnipeg compared to the new ACC/AHA
prescribed treatment times for STEMI. This study is the
first published audit of Canadian data specifically in
comparison with the ACC/AHA guideline definition.
The percentage of patients being treated in the optimal
time period was unacceptably low in both years of the
study, with even fewer patients meeting the more
stringent guidelines.  
Treatment times for hospital arrival to reperfusion (T
ER) were comparable to previously published results
(18-20). For example, in the FASTRAK II database,
which is an ongoing, prospective registry of acute
myocardial infarctions in Canada, the median time from
hospital arrival to fibrinolytic treatment in 11,574
patients from 1998 to 2000 was 43 minutes, and only
27.4% of patients were treated within 30 minutes (18).
Furthermore, in the AMI Quebec Study, where 1189
patients during the year 2003 were evaluated, the
median door-to-needle time was 32 (20-49) minutes,
with 48.8% of patients achieving the target of less than
30 minutes (19). The door-to-balloon time was 109 (79-
150) minutes, and 35.5% of patients met the required
goal of less than 90 minutes (19).  In contrast, the more
recent Calgary STEMI QIHI group showed an
impressive median door-to-balloon time of 62 minutes,
with 79% of patients meeting  the prescribed time (21).  
Following the implementation of a dedicated EKG
machine in the ER and feedback of the previous year's
results to the ER staff, it was expected that certain
components of time delay would be shortened, leading
to a concomitant improvement in reperfusion time in
the subsequent year. Despite these changes, there was
only a marginal improvement in the time to first
diagnostic EKG, but this did not translate into
meaningful reduction in time to reperfusion therapy.  
The demonstration of the treatment times in this study
indicates that systematic factors contributing to ongoing
delay remain unidentified and unresolved. Improving
patient-related factors to encourage earlier recognition
of symptoms, and thus an overall reduction in the total
ischemic time is essential, but interestingly, the REACT
2007 McGill Journal of Medicine 78Study Group in the United States was unable to
demonstrate that community intervention had a
significant impact (22). Attempts to ameliorate in-
hospital delays such as the time to first EKG is the next
logical time component to improve; however, we were
unable to demonstrate this in our investigation.
Furthermore, it would be provocative to look at the
differences in reperfusion times in patients presenting
via EMS or as a walk-in to the ER. We chose not to look
at these differences in our study due to the small sample
size, but certainly this would be important in a larger
cohort of patients. Our institution is now in the process
of attempting to coordinate EMS and ER services, as in
many cases, the diagnosis of STEMI is known prior to
ER presentation, but an ER EKG, for example, is
invariably repeated (Personal communication;
R.Grierson, WFPS/EMS Medical Director). Factors
leading to delays in treatment after obtaining the EKG
are uncertain, and we are looking further into local
factors in an ongoing, prospective fashion. Finally, there
is no local experience with pre-hospital thrombolysis,
but published data in this area is increasingly
provocative (23-26). Specifically, a meta-analysis
comparing pre-hospital thrombolysis against in-hospital
thrombolysis published in 2000 demonstrated a one
hour reduction in time to thrombolysis and a 17%
decrease in mortality (26). Furthermore, the pre-hospital
diagnosis and transfer pathway for PCI developed in
Calgary is another promising approach to finding a
solution to this problem (21).
Limitations
There were some notable limitations in this study.
Firstly, the sample size was small and included only 24
months of data. However, this was a homogenous
sample representing patients from one tertiary care
center within an urban region with five other acute care
hospitals. Secondly, we were unable to provide a
month-by-month evaluation of the hospital's
performance; instead, we looked at the data annually.
This is an important limitation, although it was
imperative that we maintain the study in a true audit
format, and by doing so, we were able to minimize the
Hawthorne effect. The Hawthorne effect is a
phenomenon whereby people may artificially change
their behavior during a research study. If we had
provided the ER physicians with monthly data as
opposed to annual data, the Hawthorne effect would
have likely been magnified, thus affecting our results.
Thirdly, we looked at the time of administration of
initial reperfusion strategy rather than the adequacy of
reperfusion, defined as an open artery by EKG
normalization and grade TIMI III flow. Finally, there is
no local experience with pre-hospital thrombolysis and
no defined established mechanism for the systematic
use of primary PCI.
Conclusion
Treatment times are longer than the newly
recommended ACC/AHA guidelines, with a minority of
patients being treated in the optimal time period at our
tertiary care center.  More comprehensive strategies and
improved coordination of medical services are required
to shorten pre-contact and post-contact response times. 
REFERENCES
1. Tu JV, Austin PC, Filate WA, Johansen HL, Brien SE, Pilote L,
Alter DA. Outcomes of acute myocardial infarction in Canada.
Can J Cardiol 2003; 19(8):893-901.
2. Guppo Italiano per lo studio della streptochinasi nell'infarcto
miocardia (GISSI investigators). Effectiveness of intravenous
thrombolytic treatment in acute myocardial infarction. Lancet
1986; 1:397-402.
3. ISIS-2 (Second International Study of Infarct Survival)
Collaborative Group. Randomized trial of intravenous
streptokinase, oral aspirin, both, or neither among 17,187 cases
of suspected acute myocardial infarction: ISIS-2. Lancet 1988;
2:349-360.
4. The GUSTO investigators. An international randomized trial
comparing four thrombolytic strategies for acute myocardial
infarction. N Engl J Med 1993; 329:673-682.
5. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.
Indications for fibrinolytic therapy in suspected acute
myocardial infarction: collaborative overview of early mortality
and major morbidity results from all randomized trials of more
than 1000 patients. Lancet 1994; 343:311-322.
6. Grines CL, Browne KF, Marco J et al. for the Primary
angioplasty in Myocardial Infarction (PAMI) Study Group. A
comparison of immediate angioplasty with thrombolytic therapy
for acute myocardial infarction. N Engl J Med 1993; 328:673-
679.
7. Anderson HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek
H, Thayssen P, et al. (DANAMI-2 Investigators). A Comparison
of Coronary Angioplasty with Fibrinolytic Therapy in Acute
Myocardial Infarction. N Engl J Med 2003; 349(8):733-742.
8. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus
intravenous thrombolytic therapy for acute myocardial
infarction: a quantitative review of 23 randomized trials. Lancet
2003; 361:13-20.
9. Nallamothu BK, Bates ER. Percutaneous coronary intervention
versus Fibrinolytic Therapy in Acute Myocardial Infarction: Is
Timing (Almost) Everything?. Am J Cardiol 2003; 92:824-826.
10. Giugliano RP, Braunwald E. Selecting the Best Reperfusion
Strategy in ST-Elevation Myocardial Infarction: It's All a Matter
of Time. Circulation 2003; 108:2828-30.
11. Gersh BJ, Stone GW, White HD, Holmes DR. Pharmacological
Facilitation of Primary Percutaneous Coronary Intervention for
Acute Myocardial Infarction: Is the Slope of the Curve the
Shape of the Future? JAMA 2005; 293:979-986.
12. ACC/AHA Guidelines for the Management of Patients with ST-
Elevation Myocardial Infarction: Executive Summary. J Am
Coll Cardiol 2004; 44:671-719.
13. Armstrong PW, Bogarty P, Buller CE, Dorian P, O'Neill BJ. The
2004 ACC/AHA Guidelines: a perspective and adaptation for
Canada by the Canadian Cardiovascular Society Working
Group. Can J Cardiol 2004; 20(11):1075-9.
14. 1999 Update: ACC/AHA Guidelines for the Management of
Vol. 10  No. 2 79 Reperfusion times for ST elevation myocardial infarction80 McGill Journal of Medicine 2007
Osganian SK, et al. the REACT Study Group. Impact of
Community Intervention to Reduce Patient Delay Time on Use
of Reperfusion Therapy for Acute Myocardial Infarction: Rapid
Early Action for Coronary Treatment (REACT) Trial. Acad
Emerg Med 2000; 7:862-872.
23. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP,
Dubien PY et al. CAPTIM Study Group. Primary angioplasty
versus prehospital fibrinolysis in acute myocardial infarction: a
randomized study. Lancet 2002; 360:825-829.
24. Armstrong PW, WEST Steering Committee. A comparison of
pharmacologic therapy with/without timely coronary
intervention vs. primary percutaneous intervention early after
ST-elevation myocardial infarction: the WEST (Which Early
ST-elevation myocardial infarction Therapy) study. European
Heart Journal 2006; 27:1530-1538.
25. Bjorklund E, Stenestrand U, Lindback J, Svensson L, Wallentin
L, Lindahl B, RIKS-HIA Investigators. Pre-hospital
thrombolysis delivered by paramedics is associated with
reduced time delay and mortality in ambulance-transported real-
life patients with ST-elevation myocardial infarction. European
Heart Journal 2006; 27:1146-1152.
26. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook
DJ. Mortality and Prehospital Thrombolysis for Acute
Myocardial Infarction: A Meta-analysis. JAMA 2000;
283(20):2686-2692.
Patients With Acute Myocardial Infarction: Executive Summary
and Recommendations. Circ 1999; 100:1016-30.
15. Interactive Resources and On-line Material. Department of
Quantitative Psychology, University of Kansas.
http://www.quantpsy.org/ (August 10, 2006). 
16. Vassar Stats: Website for Statistical Computation. Richard
Lowry, Vassar College.
http://faculty.vassar.edu/lowry/wilcoxan.html/ (1998-2006).
17. Bhagirath KM, Kass M, Chochinov AH, Avery L, Hall L, Tam
JW. Prompt treatment of STEMI: A Race Against the Clock. Can
J Cardiol 2005; 21 Supplement C: Abstract 491, 166C.
18. Davies C, Christenson J, Campbell A, Cox JL, Huynh T,
Matheson S et al. FASTRAK II Network. Fibrinolytic therapy in
acute myocardial infarction: Time to treatment in Canada. Can J
Cardiol 2004; 20(8):801-805.
19. Huynh T, O'Loughlin J, Joseph L, Schampaert E, Rinfret S,
Afilalo M et al. Delays to reperfusion therapy in acute ST-
segment elevation myocardial infarction: results from the AMI-
Quebec Study. CMAJ 2006; 175(12):1527-32.
20. Kereiakes DJ, Weaver WD, Anderson JL, Feldman T, Gibler B,
Aufderheide T et al. Time delays in the diagnosis and treatment
of acute myocardial infarction: A tale of eight cities: Report
from the Pre-hospital Study Group and the Cincinnati Heart
Project. Am Heart J 1990; 120:773-780.
21. De Villiers JS, Anderson T, McMeekin JD, Leung RCM,
Traboulsi M. Expedited transfer for primary percutaneous
coronary intervention: a program evaluation. CMAJ 2007;
176(13):1833-8.
22. Hedges JR, Feldman HA, Bittner V, Goldberg RJ, Zapka J,
Kapil M Bhagirath, MD, Kendeep S Kaila, BSc MD, a first-year resident in Internal Medicine, Malek Kass, MD FRCPC,
and James W Tam, MD FRCPC, are part of the Department of Medicine, Section of Cardiology at the University of
Manitoba. Lorraine Avery, RN BN MN CNCC(C), Lillian Hall, RN BHScN CNCC(C), are part of the Winnipeg Regional
Health Authority (WRHA) Cardiac Sciences Program and Cardiac Rehabilitation in Winnipeg, Manitoba. Alex H
Chochinov, MD is a member of the Department of Emergency Medicine, St. Boniface General Hospital, University of
Manitoba.